I
Ivan Foeldvari
Researcher at Praxis
Publications - 216
Citations - 8689
Ivan Foeldvari is an academic researcher from Praxis. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 44, co-authored 174 publications receiving 6928 citations.
Papers
More filters
Journal ArticleDOI
Update of EULAR recommendations for the treatment of systemic sclerosis
Otylia Kowal-Bielecka,Jaap Fransen,Jérôme Avouac,Mike O Becker,Mike O Becker,Agnieszka Kulak,Yannick Allanore,Oliver Distler,Philip J. Clements,Maurizio Cutolo,László Czirják,Nemanja Damjanov,Francesco Del Galdo,Christopher P. Denton,Jörg H W Distler,Ivan Foeldvari,Kim Figelstone,Marc Frerix,Daniel E. Furst,Serena Guiducci,Nicolas Hunzelmann,Dinesh Khanna,Marco Matucci-Cerinic,Ariane L. Herrick,Frank J. A. van den Hoogen,Jacob M van Laar,Gabriela Riemekasten,Richard M. Silver,Vanessa Smith,Vanessa Smith,Alberto Sulli,Ingo H. Tarner,Alan Tyndall,Joep Welling,Frederic Wigley,Gabriele Valentini,Ulrich A Walker,Francesco Zulian,Ulf Müller-Ladner +38 more
TL;DR: In this article, the European League against Rheumatism (EULAR) developed a set of recommendations for the treatment of systemic sclerosis (SSc) with attention to new therapeutic questions.
Journal ArticleDOI
Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis
Daniel J. Lovell,Nicolino Ruperto,Steven N. Goodman,Andreas Reiff,Lawrence Jung,Katerina Jarosova,Dana Nemcova,Richard Mouy,Christy Sandborg,John F. Bohnsack,Dirk Elewaut,Ivan Foeldvari,Valeria Gerloni,Jozef Rovensky,Kirsten Minden,Richard K. Vehe,L. Wagner Weiner,Gerd Horneff,Hans Iko Huppertz,Nancy Y. Olson,John R. Medich,Roberto Carcereri-De-Prati,Melissa J. McIlraith,Edward H. Giannini,Alberto Martini +24 more
TL;DR: Adalimumab therapy seems to be an efficacious option for the treatment of children with juvenile rheumatoid arthritis.
Journal ArticleDOI
Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study
Francesco Zulian,Balu H. Athreya,Ronald M. Laxer,A. M. Nelson,S. K. Feitosa de Oliveira,Marilynn Punaro,Ruben Cuttica,Gloria C. Higgins,L.W.A. van Suijlekom-Smit,Terry L. Moore,Carol B. Lindsley,Julia Garcia-Consuegra,M. O. Esteves Hilário,Loredana Lepore,Clovis A. Silva,Célia Machado,Stella Garay,Yosef Uziel,Giorgia Martini,Ivan Foeldvari,A. Peserico,P Woo,John I. Harper +22 more
TL;DR: The insidious onset of the disease, the delay in diagnosis, the recognition of mixed subtype and the better definition of the other subtypes should influence the efforts in educating trainees and practitioners and help in developing a comprehensive classification system for this syndrome.
Journal ArticleDOI
The German etanercept registry for treatment of juvenile idiopathic arthritis
Gerd Horneff,Heinrike Schmeling,T Biedermann,Ivan Foeldvari,Gerd Ganser,HJ Girschick,Toni Hospach,Hans Iko Huppertz,R. Keitzer,R. M. Küster,H Michels,D Moebius,B. Rogalski,A. Thon +13 more
TL;DR: Etanercept treatment was safe and led to a significant improvement in most JIA patients resistant to conventional treatment, and lower in patients with systemic onset arthritis.
Journal ArticleDOI
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis
Dinesh Khanna,Daniel E. Furst,Philip J. Clements,Yannick Allanore,Murray Baron,L. Czirják,Oliver Distler,Ivan Foeldvari,Masataka Kuwana,Marco Matucci-Cerinic,Maureen D. Mayes,Thomas A. Medsger,Peter A. Merkel,Janet E. Pope,James R. Seibold,Virginia D. Steen,Wendy Stevens,Christopher P. Denton +17 more
TL;DR: This state-of-art review provides a historical perspective of the development of the modified Rodnan skin score, summarizes the performance of mRSS as an outcome measure, provides guidance on assessingmRSS, and makes recommendations for incorporation of the mR SS into clinical trials.